Drug Profile
Safingol
Alternative Names: Kynac; Kynacyte; L-threo-Dihydrosphingosine; SPC 100270Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Research Triangle Park Laboratories
- Developer Eli Lilly and Company; Research Triangle Park Laboratories
- Class Chemosensitisers
- Mechanism of Action Protein kinase C inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Atopic dermatitis; Cancer; Psoriasis